The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early safety and efficacy from a phase I open-label clinical trial of CD137(4-1BB) agonistic antibody LVGN6051 as monotherapy and in combination with pembrolizumab.
 
Siqing Fu
Research Funding - Abbisko (Inst); Anaeropharma (Inst); Arrien Pharmaceuticals (Inst); AstraZeneca (Inst); BeiGene (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); Hookipa Pharma (Inst); Huya Bioscience International (Inst); IMV (Inst); Innovent Biologics (Inst); Lilly (Inst); Lyvgen Biopharma (Inst); MacroGenics (Inst); Medivir (Inst); Millennium (Inst); NCCN (Inst); NCCN (Inst); Nerviano Medical Sciences (Inst); NeuPharma, Inc. (Inst); NIH/NCI (Inst); Novartis (Inst); NovoCure (Inst); OncoMed (Inst); Parexel International, LLC (Inst); Sellas Life Sciences (Inst); Soricimed (Inst); Taiho Oncology (Inst); Tolero Pharmaceuticals (Inst); Turnstone Bio (Inst)
 
Wael A. Harb
No Relationships to Disclose
 
Sapna Pradyuman Patel
Honoraria - Merck
Consulting or Advisory Role - Cardinal Health; TriSalus Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); InxMed (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Clinica Santa Maria; Merck
Other Relationship - Immunocore
 
Charles Lu
No Relationships to Disclose
 
Daniel M. Halperin
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Chimeric Therapeutics; Curium Pharma; Ipsen; Isotopen Technologien; Lexicon; Novartis; Radiomedix
Research Funding - Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Incyte (Inst); Tarveda Therapeutics (Inst); Tersera (Inst); Thermo Fisher Scientific (Inst)
 
Yi Hsin Hsu
No Relationships to Disclose
 
Naiyi Shi
No Relationships to Disclose
 
Yuko Yamamura
No Relationships to Disclose
 
Tony Tang
No Relationships to Disclose
 
Lynn Jiang
No Relationships to Disclose
 
Fusheng Su
Consulting or Advisory Role - AstraZeneca; Lyvgen Biopharma
 
Julia Wanda Cohen
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Emmett V. Schmidt
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Jieyi Wang
Employment - Lyvgen Biopharma
Leadership - Lyvgen Biopharma
Stock and Other Ownership Interests - Bristol-Myers Squibb; Lyvgen Biopharma; Merck
Patents, Royalties, Other Intellectual Property - ABBVIE/ABBOTT; Lyvgen Biopharma
Travel, Accommodations, Expenses - Lyvgen Biopharma